Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 61 | 64 | 67 | 73 | 63 |
| Accounts receivable | 20 | 67 | -39 | 2 | -21 |
| Other Working Capital | 246 | -134 | 156 | 157 | -321 |
| Other Operating Activity | -1,377 | -1,146 | -1,129 | -1,334 | -800 |
| Operating Cash Flow | $-1,051 | $-1,149 | $-945 | $-1,102 | $-1,079 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | N/A | 0 | 0 | 0 |
| Other Investing Activity | 61 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $43 | $N/A | $0 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -1 | N/A | N/A | -3 |
| Common Stock Issued | N/A | 15 | 1,854 | 281 | 0 |
| Other Financing Activity | 385 | 0 | -4 | -1 | 0 |
| Financing Cash Flow | $385 | $13 | $1,850 | $281 | $-3 |
| Exchange Rate Effect | -2 | -9 | -18 | -38 | -7 |
| Beginning Cash Position | 3,167 | 4,420 | 3,291 | 3,675 | 4,321 |
| End Cash Position | 2,542 | 3,275 | 4,303 | 3,291 | 3,675 |
| Net Cash Flow | $-623 | $-1,136 | $905 | $-821 | $-1,082 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,051 | -1,149 | -945 | -1,102 | -1,079 |
| Capital Expenditure | -17 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -1,068 | -1,149 | -945 | -1,102 | -1,079 |